Physician profile
Aldona J Spiegel
NPI 1114956778
$758,910.91
in general payments reported to CMS, 2019-2025
23 companies · $105K in 2025
The $105K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241K · 2020: $53K · 2021: $43K · 2022: $32K · 2023: $163K · 2024: $121K · 2025: $105K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $349K · Travel and Lodging: $30K · Food and Beverage: $6,670 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,518 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $349,342.49 |
| Travel and Lodging | $29,690.07 |
| Food and Beverage | $6,669.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,517.50 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $478,815.06 | 2019-2025 | |
| Medical Device Business Services, INC. | $160,247.70 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Mentor Worldwide LLC | $81,934.98 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Axogen | $25,408.69 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Integra Lifesciences Corporation | $4,142.86 | 2023-2025 | Integra, Omnigraft, Durasorb Monofilament Mesh |
| Abbvie INC. | $2,615.99 | 2021-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Coopersurgical, INC. | $2,212.51 | 2024-2025 | Summit Doppler |
| Biom'Up France Sas | $1,000.00 | 2021 | |
| Sientra, INC. | $545.66 | 2020-2022 | |
| Allergan, INC. | $490.00 | 2019-2022 | |
| Davol INC. | $393.26 | 2022 | |
| Tela Bio, INC. | $265.49 | 2021-2024 | Ovitex 2s |
| Zimmer Biomet Holdings, INC. | $221.65 | 2019 | |
| Medtronic, INC. | $171.98 | 2022-2024 | V-Loc 180 |
| Motiva USA, LLC | $113.70 | 2024-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $93.20 | 2023 | Stravix Pl |
| Somavac Medical Solutions, INC. | $75.00 | 2022 | |
| Alafair Biosciences, INC. | $49.45 | 2022-2023 | Versawrap |
| Becton, Dickinson and Company | $43.34 | 2025 | Phasix Mesh |
| Checkpoint Surgical, INC | $30.02 | 2019 | |
| Bard Peripheral Vascular, INC. | $20.20 | 2021 | |
| Mesh Suture INC | $15.97 | 2024 | |
| Kerecis Limited | $4.20 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$115,302.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aldona Spiegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.